Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-04-29 Purchase | 2022-05-02 12:21 pm | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 804,868 | $1 | $804,868 | 11,003,365 (Indirect Direct) | View |
| 2020-12-31 Purchase | 2022-04-26 9:24 pm | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 175,000 | $0.4 | $70,000 | 10,500,702 (Indirect Direct) | View |
| 2017-09-11 Purchase | 2017-09-21 3:45 pm | Nuo Therapeutics Inc. | AURX | Boyalife Investment Fund I Inc. 10% Owner | 3,150,000 | $0.2222 | $699,930 | 4,900,000 (Direct) | View |
| 2017-08-10 Purchase | 2017-08-14 3:39 pm | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CFO CEO 10% Owner | 247,500 | $0.2222 | $54,995 | 557,336 (Indirect Direct) | View |
| 2017-08-10 Purchase | 2017-08-14 3:26 pm | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 2,045,000 | $0.29827 | $609,967 | 2,935,800 (Direct) | View |
| 2017-08-10 Purchase | 2017-08-14 3:25 pm | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 5,220,000 | $0.2222 | $1,159,884 | 8,289,677 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-04-29 Option Award | 2022-05-02 12:23 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CFO CEO | 10,532 | $1 | 2,137,858 (Direct) | View |
| 2022-04-29 Option Award | 2022-05-02 12:23 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | CLAUSEN PETER COO | 25,000 | $1 | 529,948 (Direct) | View |
| 2022-04-29 Option Award | 2022-05-02 12:22 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 100,000 | $1 | 4,343,345 (Direct) | View |
| 2022-01-01 Ownership | 2022-04-26 9:36 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | CLAUSEN PETER COO | 0 | $0 | 504,948 (Direct) | View |
| 2022-03-04 Option Award | 2022-04-26 9:35 pm | 2022-03-04 2032-03-04 | Nuo Therapeutics Inc. | AURX | Mintz Paul Director | 101,666 | $0 | 101,666 (Direct) | View |
| 2022-03-04 Option Award | 2022-04-26 9:34 pm | 2022-03-04 2032-03-04 | Nuo Therapeutics Inc. | AURX | WINZER C ERIC Director | 111,666 | $0 | 111,666 (Direct) | View |
| 2022-03-04 Option Award | 2022-04-26 9:32 pm | 2022-03-04 2032-03-04 | Nuo Therapeutics Inc. | AURX | CLAUSEN PETER COO | 43,328 | $0 | 43,328 (Direct) | View |
| 2022-03-04 Option Award | 2022-04-26 9:31 pm | 2022-03-04 2032-03-04 | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 133,334 | $0 | 133,334 (Direct) | View |
| 2022-03-04 Option Award | 2022-04-26 9:29 pm | 2022-03-04 2032-03-04 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CFO CEO | 191,672 | $0 | 191,672 (Direct) | View |
| 2021-12-31 Ownership | 2022-04-26 9:28 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 1,431,615 | $0 | 11,630,112 (Direct) | View |
| 2021-12-31 Ownership | 2022-04-26 9:28 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 0 | $0 | 11,630,112 (Indirect) | View |
| 2021-12-31 Ownership | 2022-04-26 9:28 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 1,431,615 | $0.2 | 11,630,112 (Direct) | View |
| 2021-12-31 Ownership | 2022-04-26 9:28 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 2,863,230 | $0 | 11,630,112 (Direct) | View |
| 2021-12-31 Ownership | 2022-04-26 9:26 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 900,000 | $0 | 6,365,980 (Direct) | View |
| 2021-12-31 Ownership | 2022-04-26 9:26 pm | 2020-10-05 2025-10-05 | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 1,222,635 | $0 | 6,365,980 (Direct) | View |
| 2021-12-31 Ownership | 2022-04-26 9:26 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 1,222,635 | $0 | 6,365,980 (Direct) | View |
| 2021-12-31 Ownership | 2022-04-26 9:26 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 322,635 | $0 | 6,365,980 (Direct) | View |
| 2021-12-31 Ownership | 2022-04-26 9:26 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 900,000 | $0.2 | 6,365,980 (Direct) | View |
| 2021-12-31 Ownership | 2022-04-26 9:25 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CFO CEO | 1,137,635 | $0 | 4,562,596 (Direct) | View |
| 2021-12-31 Ownership | 2022-04-26 9:25 pm | 2020-10-05 2025-10-05 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CFO CEO | 1,297,635 | $0 | 4,562,596 (Direct) | View |
| 2021-12-31 Ownership | 2022-04-26 9:25 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CFO CEO | 1,297,635 | $0 | 4,562,596 (Direct) | View |
| 2021-12-31 Ownership | 2022-04-26 9:25 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CFO CEO | 160,000 | $0 | 4,562,596 (Direct) | View |
| 2021-12-31 Ownership | 2022-04-26 9:25 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CFO CEO | 1,137,635 | $0.2 | 4,562,596 (Direct) | View |
| 2020-12-31 Ownership | 2022-04-26 9:24 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 0 | $0 | 10,500,702 (Indirect) | View |
| 2020-12-31 Ownership | 2022-04-26 9:24 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 302,205 | $0.4 | 10,500,702 (Direct) | View |
| 2020-12-31 Ownership | 2022-04-26 9:24 pm | 2020-10-05 2025-10-05 | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 1,596,615 | $0 | 10,500,702 (Direct) | View |
| 2020-12-31 Ownership | 2022-04-26 9:23 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 407,545 | $0.4 | 4,565,980 (Direct) | View |
| 2020-12-31 Ownership | 2022-04-26 9:23 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 45,000 | $0 | 4,565,980 (Direct) | View |
| 2020-12-31 Ownership | 2022-04-26 9:23 pm | 2020-10-05 2025-10-05 | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 1,222,635 | $0 | 4,565,980 (Direct) | View |
| 2020-12-31 Ownership | 2022-04-26 9:22 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CFO CEO | 432,545 | $0.4 | 2,287,326 (Direct) | View |
| 2020-12-31 Ownership | 2022-04-26 9:22 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CFO CEO | 45,000 | $0 | 2,287,326 (Direct) | View |
| 2020-12-31 Ownership | 2022-04-26 9:22 pm | 2020-10-05 2025-10-05 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CFO CEO | 1,297,635 | $0 | 2,287,326 (Direct) | View |
| 2019-12-31 Ownership | 2022-04-26 9:20 pm | 2019-11-15 2024-11-15 | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 45,000 | $0 | 60,000 (Direct) | View |
| 2019-12-31 Ownership | 2022-04-26 9:18 pm | 2019-11-15 2024-11-15 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CFO CEO | 45,000 | $0 | 60,000 (Direct) | View |
| 2018-12-31 Option Award | 2019-01-03 4:06 pm | 2018-12-31 2025-12-31 | Nuo Therapeutics Inc. | AURX | Atinsky Lawrence Director | 62,500 | $0 | 62,500 (Direct) | View |
| 2019-01-01 Option Award | 2019-01-03 12:04 pm | 2019-01-01 2026-01-01 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CFO CEO | 125,000 | $0 | 125,000 (Direct) | View |
| 2018-12-31 Option Award | 2019-01-03 11:58 am | 2018-12-31 2025-12-31 | Nuo Therapeutics Inc. | AURX | Mintz Paul Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2018-12-31 Option Award | 2019-01-03 11:52 am | 2018-12-31 2025-12-31 | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director | 62,500 | $0 | 62,500 (Direct) | View |
| 2018-12-31 Option Award | 2019-01-03 11:45 am | 2018-12-31 2025-12-31 | Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO | 81,250 | $0 | 81,250 (Direct) | View |
| 2018-12-31 Option Award | 2019-01-03 11:29 am | 2018-12-31 2015-12-31 | Nuo Therapeutics Inc. | AURX | WINZER C ERIC Director | 68,750 | $0 | 68,750 (Direct) | View |
| 2018-08-09 Option Award | 2018-08-13 4:20 pm | 2018-08-09 2025-08-09 | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 121,875 | $0 | 121,875 (Direct) | View |
| 2018-08-09 Option Award | 2018-08-13 4:10 pm | 2018-08-09 2025-08-09 | Nuo Therapeutics Inc. | AURX | Atinsky Lawrence Director | 109,375 | $0 | 109,375 (Direct) | View |
| 2018-08-09 Option Award | 2018-08-13 4:00 pm | 2018-08-09 2025-08-09 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CFO CEO | 192,710 | $0 | 192,710 (Direct) | View |
| 2018-08-09 Option Award | 2018-08-13 3:53 pm | 2018-08-09 2025-08-09 | Nuo Therapeutics Inc. | AURX | WINZER C ERIC Director | 120,313 | $0 | 120,313 (Direct) | View |
| 2018-08-09 Option Award | 2018-08-13 3:44 pm | 2018-08-09 2025-08-09 | Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO | 183,853 | $0 | 183,853 (Direct) | View |
| 2018-08-09 Option Award | 2018-08-13 3:18 pm | 2018-08-09 2025-08-08 | Nuo Therapeutics Inc. | AURX | Mintz Paul Director | 87,500 | $0 | 87,500 (Direct) | View |